Robert L. Maher
Impact in
- Geriatrics and Gerontology top 0.2%
- Pharmaceutical Practices and Patient Outcomes
- Frailty in Older Adults
- Family Practice top 1%
- Medication Adherence and Compliance
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 10
-
- Pharmacovigilance and Adverse Drug Reactions 4
- Co-authors
- Joseph T. Hanlon (6 shared papers)Emily Hajjar (3 shared papers)Sherrie L. Aspinall (2 shared papers)Kenneth E. Schmader (2 shared papers)Amanda Young (1 shared paper)Keri L. Rodriguez (1 shared paper)Michelle Rossi (1 shared paper)Cathleen J. Appelt (1 shared paper)
- Journals
- The American journal of geriatric pharmacotherapy (2 papers)American Journal of Health-System Pharmacy (2 papers)American Journal of Pharmaceutical Education (2 papers)Journal of the American Pharmacists Association (1 paper)Expert Opinion on Drug Safety (1 paper)
- Partner nations
- United StatesSloveniaUnited Kingdom
In The Last Decade
Robert L. Maher
15 papers receiving 1.5k citations
Robert L. Maher's Hit Papers
Peers
Comparison fields: 5 of 108
- Geriatrics and Gerontology 764
- Family Practice 146
- Toxicology 68
- Applied Microbiology and Biotechnology 34
- Economics and Econometrics 224
Countries citing papers authored by Robert L. Maher
This map shows the geographic impact of Robert L. Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Maher more than expected).
Fields of papers citing papers by Robert L. Maher
This network shows the impact of papers produced by Robert L. Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Maher. The network helps show where Robert L. Maher may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert L. Maher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical consequences of polypharmacy in elderly Hit paper breakdown → | 2013 | 1337 |
| 2 | 2007 | 64 | |
| 3 | 2002 | 32 | |
| 4 | 2001 | 23 | |
| 5 | 2010 | 21 | |
| 6 | 2007 | 14 | |
| 7 | 2004 | 14 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 6 | |
| 10 | 2002 | 5 | |
| 11 | 2012 | 5 | |
| 12 | 2004 | 2 | |
| 13 | Psychiatric manifestations of medications in the elderly | 2012 | 2 |
| 14 | 2004 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2002 | 1 |
About Robert L. Maher
Robert L. Maher is a scholar working on Geriatrics and Gerontology, Toxicology, Pediatrics, Perinatology and Child Health, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 16 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers), Pharmaceutical studies and practices (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers), Medication Adherence and Compliance (2 papers), Pharmacy and Medical Practices (1 paper) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Geriatrics and Gerontology (764 citations), Family Practice (146 citations), Toxicology (68 citations), Applied Microbiology and Biotechnology (34 citations) and Economics and Econometrics (224 citations). Robert L. Maher has collaborated with scholars based in United States, Slovenia and United Kingdom. Frequent co-authors include Joseph T. Hanlon, Emily Hajjar, Sherrie L. Aspinall, Kenneth E. Schmader, Amanda Young, Keri L. Rodriguez, Michelle Rossi, Cathleen J. Appelt, Subashan Perera and Chester B. Good. Their work appears in journals such as The American journal of geriatric pharmacotherapy, American Journal of Health-System Pharmacy, American Journal of Pharmaceutical Education, Journal of the American Pharmacists Association and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.